Yoshika Nagata

Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer

Takeshi Hanagiri, Masakazu Sugaya, Masaru Takenaka et al. · Lung Cancer · 2011 · 82 citations

Medicine, Oncology, Surgery +11

Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both <i> in vivo</i> and <i>in vitro</i>

Takashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada et al. · Cancer Science · 2007 · 79 citations · Full text

Life Sciences, Immunology, Oncology +17

Results of a Surgical Resection for Patients With Stage IV Non–Small-Cell Lung Cancer

Takeshi Hanagiri, Masaru Takenaka, Soich Oka et al. · Clinical Lung Cancer · 2011 · 53 citations

Medicine, Oncology, Surgery +12

The prognostic significance of HER2 overexpression in non-small cell lung cancer.

Masaru Takenaka, Takeshi Hanagiri, Shinji Shinohara et al. · PubMed · 2011 · 38 citations

Medicine, Oncology, Pathology +17

Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer

Takeshi Hanagiri, Yoshiki Shigematsu, Shinji Shinohara et al. · Lung Cancer · 2013 · 33 citations

Life Sciences, Immunology, Oncology +17